Osborn Stephanie L, So Michelle, Hambro Shannon, Nolta Jan A, Kurzrock Eric A
1Department of Urology, University of California, Davis School of Medicine, Sacramento, California.
2Stem Cell Program, Institute for Regenerative Cures, University of California, Davis Medical Center, Sacramento, California.
Tissue Eng Part A. 2015 Jun;21(11-12):1906-15. doi: 10.1089/ten.TEA.2014.0630. Epub 2015 Apr 22.
Bioengineered bladder tissue is needed for patients with neurogenic bladder disease as well as for cancer. Current technologies in bladder tissue engineering have been hampered by an inability to efficiently initiate blood supply to the graft, ultimately leading to complications that include graft contraction, ischemia, and perforation. To date, the biological mechanisms of vascularization on transplant have not been suitably investigated for urologic tissues. To better understand the mechanisms of neovascularization on bladder wall transplant, a chimeric mouse model was generated such that angiogenesis and vasculogenesis could be independently assessed in vivo. Green fluorescence protein (GFP) transgenic mice received bone marrow transplants from β-galactosidase (LacZ) transgenic animals and then subsequent bladder wall transplants from wild-type donor mice. Before euthanization, the aorta was infused with fluorescent microbeads (fluorospheres) to identify perfused vessels. The contributions of GFP (angiogenesis) and LacZ (vasculogenesis) to the formation of CD31-expressing blood vessels within the wild-type graft were evaluated by immunohistochemistry at different time points and locations within the graft (proximal, middle, and distal) to provide a spatiotemporal analysis of neovascularization. The GFP index, a measure of angiogenic host ingrowth, was significantly higher at proximal versus mid or distal regions in animals 2-16 weeks post-transplant. However, GFP index did not increase over time in any area. Within 7 days post-transplant, perfusion of primarily wild-type, donor blood vessels in the most distal areas of the graft was observed by intraluminal fluorospheres. In addition, chimeric host-donor (GFP-wild type) blood vessels were evident in proximal areas. The contribution of vasculogenesis to vascularization of the graft was limited, as LacZ cells were not specifically associated with the endothelial cells of blood vessels, but rather found primarily in areas of inflammation. The data suggest that angiogenesis of host blood vessels into the proximal region leads to inosculation between host and donor vessels and subsequent perfusion of the graft via pre-existing graft vessels within the first week after transplant. As such, the engineering of graft blood vessels and the promotion of inosculation might prevent graft contraction, thereby potentiating the use of bioengineered bladder tissue for transplantation.
神经源性膀胱疾病患者以及癌症患者都需要生物工程膀胱组织。目前膀胱组织工程技术因无法有效地启动移植物的血液供应而受到阻碍,最终导致包括移植物收缩、缺血和穿孔在内的并发症。迄今为止,尚未对泌尿外科组织移植时血管化的生物学机制进行充分研究。为了更好地理解膀胱壁移植时新生血管形成的机制,构建了一种嵌合小鼠模型,以便能够在体内独立评估血管生成和血管发生。绿色荧光蛋白(GFP)转基因小鼠接受来自β-半乳糖苷酶(LacZ)转基因动物的骨髓移植,随后接受来自野生型供体小鼠的膀胱壁移植。在安乐死之前,向主动脉注入荧光微珠(荧光球)以识别灌注血管。通过免疫组织化学在移植物内不同时间点和位置(近端、中间和远端)评估GFP(血管生成)和LacZ(血管发生)对野生型移植物内表达CD31的血管形成的贡献,以提供新生血管形成的时空分析。GFP指数是血管生成性宿主向内生长的一个指标,在移植后2至16周的动物中,近端区域的GFP指数明显高于中间或远端区域。然而,GFP指数在任何区域都没有随时间增加。移植后7天内,通过腔内荧光球观察到移植物最远端区域主要是野生型供体血管的灌注。此外,嵌合的宿主-供体(GFP-野生型)血管在近端区域很明显。血管发生对移植物血管化的贡献有限,因为LacZ细胞并非特异性地与血管内皮细胞相关,而是主要存在于炎症区域。数据表明,宿主血管向近端区域的血管生成导致宿主和供体血管之间的吻合,随后在移植后第一周通过移植物内预先存在的移植物血管对移植物进行灌注。因此,移植物血管的工程构建和吻合的促进可能会防止移植物收缩,从而增强生物工程膀胱组织在移植中的应用。